🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
RATIONALE: Monoclonal antibodies, such as rituximab and yttrium Y 90 ibritu...
Status
Completed
Location
Comprehensive Cancer Center at University of Alabama at Birmingham
Start Date
2003-11
Trial ID
NCT00070447
This study is designed to compare the number of infusion reactions to treat...
Status
Completed
Location
St.Joseph Heritage Care
Start Date
2020-03-25
Trial ID
NCT04189588
Treatments Being Tested
The purpose of this study is to determine the complete response rate when C...
Status
Completed
Location
UPMC Cancer Centers
Start Date
2003-11
Trial ID
NCT00177554
Treatments Being Tested
RATIONALE: Monoclonal antibodies, such as rituximab, can block cancer growt...
Status
Unknown
Location
Medizinische Klinik, Klinikum Augsburg
Start Date
2005-06
Trial ID
NCT00397800
Treatments Being Tested
This phase III trial studies rituximab and yttrium Y-90 ibritumomab tiuxeta...
Status
Terminated
Location
Mayo Clinic in Rochester
Start Date
2015-02-11
Trial ID
NCT02320292
Treatments Being Tested
RATIONALE: Radiolabeled monoclonal antibodies can locate tumor cells and de...
Status
Completed
Location
University of Alabama at Birmingham Comprehensive Cancer Center
Start Date
1999-11
Trial ID
NCT00005592
Treatments Being Tested
RATIONALE: Monoclonal antibodies such as rituximab and yttrium Y 90 ibritum...
Status
Completed
Location
Memorial Sloan Kettering Cancer Center
Start Date
2003-02-10
Trial ID
NCT00058422
The goal of this clinical research study is to see if high-dose chemotherap...
Status
Completed
Location
UT MD Anderson Cancer Center
Start Date
2003-09
Trial ID
NCT01538472
Treatments Being Tested
This randomized phase III trial studies 90-yttrium ibritumomab tiuxetan and...
Status
Terminated
Location
City of Hope Medical Center
Start Date
2015-01
Trial ID
NCT02366663